April 29, 2025

Can Five Proteins Predict Liver Disease?

"Imagine if we could predict risk of metabolic dysfunction-associated steatotic liver disease (MASLD) years before it starts."

Conexiant

April 24, 2025

Old Drug, New Trick for Joint Pain

Can a common diabetes drug double as a treatment for knee osteoarthritis?

Conexiant

April 21, 2025

Risk-Free Midlife: 10+ Years Longer Living

Prioritizing the prevention and treatment of the modifiable risk factors could substantially extend healthy life expectancy worldwide.

Conexiant

April 04, 2025

Local Excision May Be Feasible in Patients With Low Rectal Adenocarcinoma

Chemotherapy followed by local excision may be effective in patients with node-negative low rectal adenocarcinoma, according to findings presented at the 2025 Society of Surgical Oncology Annual Meeti...

The ASCO Post

April 01, 2025

AI Scribing and Telephone Management

In his ASCRS 2025 presentation titled "AI Scribing and Telephone Management," Robert T. Chang, MD, shared his insights about how artificial intelligence has impacted his practice and how it can help other practices to be more efficient.

Ophthalmology Management

September 09, 2024

Bariatric Surgery Outperformed Meds for Hypertension Control

Meta-analysis reveals bariatric surgery patients 7 times more likely to reduce antihypertensive medications compared to conventional treatment.

Conexiant

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

December 02, 2024

Can Hidden Fat Predict Alzheimer's Risk?

A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.

Conexiant

May 22, 2024

DDW: Adjuvant Therapy May Improve Rectal Adenocarcinoma Survival

Adjuvant therapy may be underutilized in patients with clinical T2N0 rectal adenocarcinoma, according to new findings presented at Digestive Disease Week 2024.

Conexiant